Sofwave Medical Ltd has achieved a major milestone by obtaining FDA clearance for its SUPERB technology to improve the appearance of cellulite. This approval comes amid a booming cellulite treatment market and underscores the company’s commitment to innovative non-invasive solutions.
In a study involving 68 women, blinded reviewers accurately identified 89 percent of subjects’ photographs after treatment, highlighting the effectiveness and reliability of the technology. Chairman Dr. Shimon Eckhouse noted that cellulite affects women of all ages and that existing treatments often fall short in safety or efficacy.
With FDA clearance in hand, Sofwave is poised to accelerate growth and deliver a safe, effective alternative for addressing cellulite. This breakthrough reinforces the company’s position as a leader in non-invasive aesthetic medical devices.
Explore more articles you might find interesting
